Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 4, 2017
Evogene Files Annual Report for the Year Ended December 31, 2016
REHOVOT, Israel, May 04, 2017 (GLOBE NEWSWIRE) -- Evogene Ltd. (EVGN) (EVGN), a leading company for the improvement of crop productivity and economics for food, feed ...
May 4, 2017
Neovacs to Present Clinical Development Update On IFNα Kinoid in Dermatomyositis
PARIS and BOSTON, May 04, 2017 (GLOBE NEWSWIRE) -- Neovacs (Alternext Paris:ALNEV), a leader in active immunotherapies for the treatment of autoimmune diseases, today announced ...
May 4, 2017
Eiger BioPharmaceuticals to Host Key Opinion Leader Event Addressing Need for Novel Mechanisms in the Treatment of Pulmonary Arterial Hypertension (PAH) on May 10th in New York City
PALO ALTO, Calif., May 4, 2017 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, will host ...
May 4, 2017
CymaBay to Report First Quarter 2017 Financial Results on Thursday, May 11
NEWARK, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for specialty and orphan diseases ...
May 4, 2017
Minerva Neurosciences Reports First Quarter 2017 Financial Results and Business Updates
WALTHAM, Mass., May 04, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
May 4, 2017
Rockwell Medical Mails Letter to Shareholders Profiling Independent Director Nominee David Domzalski
WIXOM, Mich., May 04, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) today mailed a letter to its shareholders in connection with the Company's upcoming ...
May 4, 2017
Onconova Therapeutics, Inc. to Provide Corporate Update and First Quarter 2017 Financial Results
NEWTOWN, Pa., May 04, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products ...
May 4, 2017
Rexahn Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update
ROCKVILLE, Md., May 04, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:<a href="http://www.nasdaq.com/symbol/rnn">RNN</a>), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the ...
May 4, 2017
Immune Pharmaceuticals Announces Private Placement of up to $3.4 Million Read more: http://www.nasdaq.com/press-release/immune-pharmaceuticals-announces-private-placement-of-up-to-34-million-20170504-01088#ixzz4g7TwxwKz
NEW YORK, May 4, 2017 /PRNewswire/ -- Immune Pharmaceuticals Inc. (Nasdaq:IMNP) ("Immune" or the "Company") today announced that it has entered into definitive agreements with several ...
May 3, 2017
LifeSci Advisors Expands Corporate Access Team with Appointment of Tara Hartigan
NEW YORK, May 03, 2017 (GLOBE NEWSWIRE) -- LifeSci Advisors, LLC (the "Company" or "LifeSci"), the leading international investor relations and corporate communications firm dedicated ...
May 2, 2017
Revolt Against Sky-High Drug Prices Prompts a Pioneer to Cash Out
Entrepreneur Jeffrey Aronin said a few years ago he hoped to eventually sell Marathon Pharmaceuticals LLC, which he controls and runs, for billions of dollars, ...
May 2, 2017
Perrigo Says Investigators Searched Its Offices in Generic-Drug Probe
Perrigo Co. PRGO -5.09% said Tuesday its offices were searched by investigators conducting a federal probe of price collusion in the generic-drug industry. ...
Page 120 of 120